+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID06814574

Study on Pacemaker Implantation After Transcatheter Tricuspid Valve Replacement at a Single Center

Led by Deutsches Herzzentrum Muenchen · Updated on 2025-02-07

25

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research focuses on patients who have undergone transcatheter tricuspid valve replacement TTVR, a procedure linked with a high risk of developing third-degree atrioventricular block AVB. The study aims to find the best method for pacemaker implantation to manage this risk effectively. It is an observational study conducted to understand the optimal therapeutic approach for pacemaker use after TTVR. Participants in this study have received TTVR and are monitored for pacemaker implantation. The study evaluates the success, feasibility, and safety of pacemaker implantation at the time of surgery and follows participants for an average of six months to assess ongoing electric performance and procedural details related to the pacemaker. During the study, participants will be closely observed through surgery and follow-up visits over approximately six months. Researchers will assess the safety and effectiveness of the pacemaker implantation, including the type of pacemaker used and its electrical functioning. The overall goal is to improve management strategies for patients requiring pacemakers after TTVR.

CONDITIONS

Brief Title

Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

Research Team

C

Carsten Lennerz, PD Dr. med.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here